Related Experiment Video
Updated: Nov 15, 2025
10:41
An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
10.6K
Critical regulatory levels in tumor differentiation: Signaling pathways, epigenetics and non-coding transcripts
Fatemeh Zolghadr1, Babak Bakhshinejad2, Sapir Davuchbabny1
1School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia.
Summary
Differentiation therapy aims to manage cancer by targeting pathways that reduce tumor cell plasticity. This approach requires tailored strategies due to cancer type heterogeneity.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Therapy
Background:
- Tumor plasticity is linked to increased cancer aggression, metastasis, and therapy resistance.
- Inducing tumor cell differentiation offers a strategy to achieve manageable, therapy-naïve states.
- Current differentiation therapy approaches require cancer-specific adaptations.
Purpose of the Study:
- To explore signaling pathways, epigenetics, and non-coding RNAs as key regulators for differentiation therapy.
- To highlight the necessity of personalized approaches in differentiation therapy due to tumor heterogeneity.
Main Methods:
- Review of current literature on tumor differentiation mechanisms.
- Analysis of signaling pathways involved in cancer cell plasticity.
- Examination of epigenetic modifications and non-coding RNAs in cancer differentiation.
Main Results:
- Signaling pathways, epigenetics, and non-coding RNAs are identified as crucial targets for inducing tumor differentiation.
- Tumor cell plasticity is a key characteristic driving aggressive cancer phenotypes.
- Cancer type-specific genetic and phenotypic landscapes necessitate tailored differentiation therapy strategies.
Conclusions:
- Differentiation therapy holds promise for managing cancer by targeting plasticity.
- Effective differentiation therapy requires a deep understanding of cancer-specific regulatory mechanisms.
- Future research should focus on developing personalized differentiation-based treatment strategies.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
01:37Epigenetic Regulation
3.4K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.4K
01:46Epigenetic Regulation
32.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.0K
01:19Interactions Between Signaling Pathways
6.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K
03:03mTOR Signaling and Cancer Progression
4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.1K
02:07Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K